EphA2 has been shown to be activated through the phosphorylation on serine 897 mediated by AKT, RSK, and PKA kinases and alters downstream signaling, and then facilitating tumor progression (Zhou et al., 2015; Barquilla et al., 2016). The gene discussed is AKT1; the disease is neoplasm.